Thermo Fisher Scientific ( TMO) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.7%. By the end of trading, Thermo Fisher Scientific rose $1.97 (2.4%) to $85.37 on average volume. Throughout the day, 3,206,947 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2,979,100 shares. The stock ranged in a price between $84.00-$85.76 after having opened the day at $84.09 as compared to the previous trading day's close of $83.40. Other companies within the Health Care sector that increased today were: Mela ( MELA), up 17.6%, ZIOPHARM Oncology ( ZIOP), up 16.2%, Cytokinetics ( CYTK), up 11.1% and Intercept Pharmaceuticals ( ICPT), up 9.8%.
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $29.8 billion and is part of the health services industry. The company has a P/E ratio of 23.0, above the S&P 500 P/E ratio of 17.7. Shares are up 30.8% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold. TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.